Smartleaf Asset Management »

Enliven Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $16 1 16.00

More positions owned by Smartleaf Asset Management

Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Smartleaf Asset Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Vestal Point Capital
Fairmount Funds Management
BlackRock
Polar Capital Holdings
VR Adviser
Vanguard Group
Henderson Group
Point72 Asset Management
Novo A/S
Blackstone Group
Capital Research Global Investors
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics